Regulator of chromosome condensation 1 (RCC1) as a novel therapeutic target in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Bannoura, Sahar F.
Khan, Husain Y.
Aboukameel, Amro
Uddin, Md Hafiz
Nimri, Rund
Beal, Eliza
Kim, Seongho
Al Hallak, Mohammed Najeeb
El-Rayes, Bassel
Philip, Philip A.
Pasche, Boris
Mohammad, Ramzi
Azmi, Asfar S.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5587
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5587
引用
收藏
页数：2
相关论文
共 50 条
  • [41] HNF1A is a Novel and Critical Target of BET-Inhibitors in Pancreatic Ductal Adenocarcinoma
    不详
    PANCREAS, 2022, 51 (07) : 875 - 875
  • [42] Colony-stimulating factor-1 receptor as a potential therapeutic target in pancreatic ductal adenocarcinoma
    Chaudhuri, Somak
    Deming, Dustin A.
    Pasch, Cheri A.
    Johnson, Katherine A.
    Sievers, Chelsie K.
    Emmerich, Philip B.
    CANCER RESEARCH, 2024, 84 (06)
  • [43] CHROMOSOME CONDENSATION CAUSED BY LOSS OF RCC1 FUNCTION REQUIRES THE CDC25C PROTEIN THAT IS LOCATED IN THE CYTOPLASM
    SEKI, T
    YAMASHITA, K
    NISHITANI, H
    TAKAGI, T
    RUSSELL, P
    NISHIMOTO, T
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (12) : 1373 - 1388
  • [44] CATALYSIS OF GUANINE-NUCLEOTIDE EXCHANGE ON RAN BY THE MITOTIC REGULATOR RCC1
    BISCHOFF, FR
    PONSTINGL, H
    NATURE, 1991, 354 (6348) : 80 - 82
  • [45] Long noncoding RNA PANCRNA1 is a novel regulator of cell growth and motility in pancreatic ductal adenocarcinoma
    Karaboga, Husna
    Jonsson, Philip
    Liu, Yu
    Lin, Chin-Yo
    CANCER RESEARCH, 2016, 76
  • [46] Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics
    Liu, Xinlu
    Weng, Yejing
    Liu, Peng
    Sui, Zhigang
    Zhou, Lei
    Huang, Yinpeng
    Zhang, Lihua
    Zhang, Yukui
    Tan, Xiaodong
    ONCOTARGETS AND THERAPY, 2018, 11 : 3345 - 3357
  • [47] Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma
    Wang, Simin
    Xiong, Yangjie
    Luo, Yuxiang
    Shen, Yanying
    Zhang, Fengrui
    Lan, Haoqi
    Pang, Yuzhi
    Wang, Xiaofang
    Li, Xiaoqi
    Zheng, Xufen
    Lu, Xiaojing
    Liu, Xiaoxiao
    Cheng, Yumei
    Wu, Tanwen
    Dong, Yue
    Lu, Yuan
    Cui, Jiujie
    Jia, Xiaona
    Yang, Sheng
    Wang, Liwei
    Wang, Yuexiang
    EMBO MOLECULAR MEDICINE, 2024, 16 (05) : 1115 - 1142
  • [48] HMGA1 identified as a therapeutic target in pancreatic adenocarcinoma
    Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (3): : 126 - 127
  • [49] Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma
    Xi Wang
    Cheng-Sheng Zhang
    Xu-Yuan Dong
    Yuan Hu
    Bao-Jun Duan
    Jun Bai
    Yin-Ying Wu
    Lin Fan
    Xin-Hua Liao
    Ye Kang
    Peng Zhang
    Meng-Yang Li
    Jiao Xu
    Zhi-Jun Mao
    Hui-Tong Liu
    Xiao-Long Zhang
    Li-Fei Tian
    En-Xiao Li
    World Journal of Gastrointestinal Oncology, 2022, 14 (07) : 1252 - 1264
  • [50] CXCR1: A novel therapeutic avenue for CSC- like phenotypes in pancreatic ductal adenocarcinoma
    Molczyk, Caitlin
    Thomas, Elizabeth
    Zaman, Lubaba
    Goel, Paran
    Singh, Rakesh K.
    CANCER RESEARCH, 2022, 82 (12)
12345